Hakuehdot

NeuroQ 3.0

PET scan analysis tool

Find similar products

NeuroQ 3.0™ is a powerful tool to assist clinicians with interpretations of brain PET scans. NeuroQ helps with the differential diagnosis of dementia and allows a physician to monitor the progress of a patient’s disease.

Contact
Features
Automated analysis

Automated analysis for disease monitoring

NeuroQ 3.0 helps you save time with its automated analysis and quantification of relative activity in multiple brain regions. It's a user-friendly clinical tool that can automatically identify and quantify differences between two FDG-PET studies of the same patient.

Automated analysis for disease monitoring

NeuroQ 3.0 helps you save time with its automated analysis and quantification of relative activity in multiple brain regions. It's a user-friendly clinical tool that can automatically identify and quantify differences between two FDG-PET studies of the same patient.

Automated analysis for disease monitoring

NeuroQ 3.0 helps you save time with its automated analysis and quantification of relative activity in multiple brain regions. It's a user-friendly clinical tool that can automatically identify and quantify differences between two FDG-PET studies of the same patient.
Anomaly detection

Anomaly detection helps diagnostics

NeuroQ 3.0 helps detect clinically meaningful abnormalities of regional brain metabolism.

Anomaly detection helps diagnostics

NeuroQ 3.0 helps detect clinically meaningful abnormalities of regional brain metabolism.

Anomaly detection helps diagnostics

NeuroQ 3.0 helps detect clinically meaningful abnormalities of regional brain metabolism.
Built-in comparison

Built-in comparison with asymptomatic control subjects

NeuroQ 3.0 compares the regional brain activity in an individual scan to activity values derived from a group of asymptomatic control subjects.

Built-in comparison with asymptomatic control subjects

NeuroQ 3.0 compares the regional brain activity in an individual scan to activity values derived from a group of asymptomatic control subjects.

Built-in comparison with asymptomatic control subjects

NeuroQ 3.0 compares the regional brain activity in an individual scan to activity values derived from a group of asymptomatic control subjects.
Optional EQuAL

Optional EQuAL helps determine prognosis of TLE surgery

NeuroQ 3.0 offers an optional application called EQuAL, which is a unique neuro imaging analysis tool for brain PET imaging of temporal lobe epilepsy (TLE). EQuAL analysis provides a non-invasive way to determine, in advance of TLE surgery, the likelihood that a patient will become seizure-free after surgery.

Optional EQuAL helps determine prognosis of TLE surgery

NeuroQ 3.0 offers an optional application called EQuAL, which is a unique neuro imaging analysis tool for brain PET imaging of temporal lobe epilepsy (TLE). EQuAL analysis provides a non-invasive way to determine, in advance of TLE surgery, the likelihood that a patient will become seizure-free after surgery.

Optional EQuAL helps determine prognosis of TLE surgery

NeuroQ 3.0 offers an optional application called EQuAL, which is a unique neuro imaging analysis tool for brain PET imaging of temporal lobe epilepsy (TLE). EQuAL analysis provides a non-invasive way to determine, in advance of TLE surgery, the likelihood that a patient will become seizure-free after surgery.
  • Automated analysis
  • Anomaly detection
  • Built-in comparison
  • Optional EQuAL
See all features
Automated analysis

Automated analysis for disease monitoring

NeuroQ 3.0 helps you save time with its automated analysis and quantification of relative activity in multiple brain regions. It's a user-friendly clinical tool that can automatically identify and quantify differences between two FDG-PET studies of the same patient.

Automated analysis for disease monitoring

NeuroQ 3.0 helps you save time with its automated analysis and quantification of relative activity in multiple brain regions. It's a user-friendly clinical tool that can automatically identify and quantify differences between two FDG-PET studies of the same patient.

Automated analysis for disease monitoring

NeuroQ 3.0 helps you save time with its automated analysis and quantification of relative activity in multiple brain regions. It's a user-friendly clinical tool that can automatically identify and quantify differences between two FDG-PET studies of the same patient.
Anomaly detection

Anomaly detection helps diagnostics

NeuroQ 3.0 helps detect clinically meaningful abnormalities of regional brain metabolism.

Anomaly detection helps diagnostics

NeuroQ 3.0 helps detect clinically meaningful abnormalities of regional brain metabolism.

Anomaly detection helps diagnostics

NeuroQ 3.0 helps detect clinically meaningful abnormalities of regional brain metabolism.
Built-in comparison

Built-in comparison with asymptomatic control subjects

NeuroQ 3.0 compares the regional brain activity in an individual scan to activity values derived from a group of asymptomatic control subjects.

Built-in comparison with asymptomatic control subjects

NeuroQ 3.0 compares the regional brain activity in an individual scan to activity values derived from a group of asymptomatic control subjects.

Built-in comparison with asymptomatic control subjects

NeuroQ 3.0 compares the regional brain activity in an individual scan to activity values derived from a group of asymptomatic control subjects.
Optional EQuAL

Optional EQuAL helps determine prognosis of TLE surgery

NeuroQ 3.0 offers an optional application called EQuAL, which is a unique neuro imaging analysis tool for brain PET imaging of temporal lobe epilepsy (TLE). EQuAL analysis provides a non-invasive way to determine, in advance of TLE surgery, the likelihood that a patient will become seizure-free after surgery.

Optional EQuAL helps determine prognosis of TLE surgery

NeuroQ 3.0 offers an optional application called EQuAL, which is a unique neuro imaging analysis tool for brain PET imaging of temporal lobe epilepsy (TLE). EQuAL analysis provides a non-invasive way to determine, in advance of TLE surgery, the likelihood that a patient will become seizure-free after surgery.

Optional EQuAL helps determine prognosis of TLE surgery

NeuroQ 3.0 offers an optional application called EQuAL, which is a unique neuro imaging analysis tool for brain PET imaging of temporal lobe epilepsy (TLE). EQuAL analysis provides a non-invasive way to determine, in advance of TLE surgery, the likelihood that a patient will become seizure-free after surgery.

Napsauttamalla linkkiä poistut viralliselta Philips Electronics Ltd:n ("Philips") verkkosivustolta. Kaikki tällä sivustolla mahdollisesti olevat linkit kolmansien osapuolten verkkosivustoille tarjotaan vain avuksesi, eivätkä ne millään tavalla edusta minkäänlaista yhteyttä tai tukea näillä linkitetyillä verkkosivustoilla annettuihin tietoihin. Philips ei anna minkäänlaisia väitteitä tai takuita kolmansien osapuolien verkkosivustoista tai niiden sisältämistä tiedoista.

Ymmärrän

You are about to visit a Philips global content page

Continue

Napsauttamalla linkkiä poistut viralliselta Philips Electronics Ltd:n ("Philips") verkkosivustolta. Kaikki tällä sivustolla mahdollisesti olevat linkit kolmansien osapuolten verkkosivustoille tarjotaan vain avuksesi, eivätkä ne millään tavalla edusta minkäänlaista yhteyttä tai tukea näillä linkitetyillä verkkosivustoilla annettuihin tietoihin. Philips ei anna minkäänlaisia väitteitä tai takuita kolmansien osapuolien verkkosivustoista tai niiden sisältämistä tiedoista.

Ymmärrän

You are about to visit a Philips global content page

Continue
© Koninklijke Philips N.V., 2004 - 2025. Kaikki oikeudet pidätetään.

Sivustomme sopii parhaiten uusimmille Microsoft Edge-, Google Chrome- ja Firefox-selaimille.